Neuralink Co-founder Max Hodak to Detail Science Corp's Brain-Computer Interface at TechCrunch Disrupt 2026
Max Hodak, CEO of Science Corporation and Neuralink co-founder, will speak at TechCrunch Disrupt 2026 in San Francisco about his company's biohybrid brain-computer interface, which has recruited a leading neurobiologist to run its first U.S. human trials. In his Disrupt Stage session, Hodak will argue that computing is moving beyond screens toward interfaces built directly on brain-computer interaction.
GoKawiil's interpretation of the reporting above, not reported fact.
Hodak's remarks signal that serious commercial and scientific momentum is building behind neural interfaces as a mainstream computing paradigm, not just a research curiosity. His track record founding both Neuralink and Science Corporation gives his predictions added weight among investors evaluating where hardware innovation is headed next.
- Science Corp is starting first U.S. human trials for a biohybrid brain-computer interface.
- Max Hodak will present his 'post-screen' vision at TechCrunch Disrupt 2026 in October.
- Hodak previously co-founded Neuralink and Transcriptic before launching Science Corporation in 2021.
Source: techcrunch.com — Techcrunch Events, 2026-09-16
Published there as: “Hear why Neuralink co-founder Max Hodak says the screen era is ending at TechCrunch Disrupt 2026”
Read the original report → The summary and analysis above are GoKawiil's own, written from reporting by the source above. Facts and quotes belong to the original publisher.